BSX•benzinga•
Boston Scientific To Acquire SoniVie For $400 Million, Expanding Hypertension Treatment Portfolio
Summary
Boston Scientific will acquire SoniVie for up to $600 million on 100% basis, adding the TIVUS ultrasound system to its hypertension treatment pipeline. Deal closes in H1 2025.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 3, 2025 by benzinga